Sakar Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

200.60 +6.60 ▲3.4%

31 March 2023, 03:46:43 PM
Volume: 22,604

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sakarhealthcare.com
Market Cap 381.94 Cr.
Enterprise Value(EV) 481.89 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 9.34 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.48 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 84.41 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.38 Calculated using Price: 200.60
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.90 Cr. 19,040,000 Shares
FaceValue 10
Company Profile
The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.40%
1 Week
-5.22%
1 Month
-11.02%
3 Month
-10.55%
6 Month
-3.46%
1 Year
+48.43%
2 Year
+77.37%
5 Year
+237.14%
10 Year

Ratios View Details >>

3 years 2020-03 2021-03 2022-03
Return on Equity (%) 11.83 11.88 13.44
Return on Capital Employed (%) 14.79 13.16 12.09
Return on Assets (%) 8.36 7.30 6.81

Balance Sheet View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 81 98 127 155
Non Curr. Liab. 20 46 94 97
Curr. Liab. 14 33 47 46
Minority Int.
Equity & Liab. 115 178 268 298
Non Curr. Assets 93 144 218 242
Curr. Assets 22 34 50 55
Misc. Exp. not W/O
Total Assets 115 178 268 298

Profit Loss View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 83 95 128 129
Other Income 2 1 2 4
Total Income 85 96 130 133
Total Expenditure -63 -72 -99 -95
PBIDT 22 24 32 38
Interest -2 -2 -3 -4
Depreciation -7 -8 -10 -15
Taxation -3 -3 -4 -1
Exceptional Items
PAT 10 11 15 18
Minority Interest
Share Associate
Other Related Items 0
Consolidated Net Profit 10 11 15 18
Adjusted EPS 6 7 9 10

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 19 15 36
Cash Fr. Inv. -22 -47 -90
Cash Fr. Finan. 3 32 55
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 72.88 74.02 67.54 67.54 67.54 67.54 67.54 62.10 62.10
Public 27.12 25.97 32.46 32.46 32.46 32.46 32.46 37.90 37.90
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 28 Mar 2023
Trading Window
Sakar Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Mon, 27 Mar 2023
Trading Window
Sakar Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fri, 10 Mar 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Sakar Healthcare Limited has informed the Exchange about Schedule of meet

Technical Scans View Details >>

Fri, 31 Mar 2023
Opening at Low Opening at Low
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Sakar Healthcare Ltd.

What is Sakar Healthcare share price?
Can I buy Sakar Healthcare shares now?
What is the Market Cap of Sakar Healthcare?
What are the key metrics to analyse Sakar Healthcare?
What is the 52 Week High and Low of Sakar Healthcare?
What is the trend of Sakar Healthcare share price?